Mesa Laboratories, Inc. (NASDAQ:MLAB) declared a quarterly dividend on Tuesday, October 3rd, Wall Street Journal reports. Stockholders of record on Thursday, November 30th will be given a dividend of 0.16 per share by the medical instruments supplier on Friday, December 15th. This represents a $0.64 annualized dividend and a dividend yield of 0.42%. The ex-dividend date of this dividend is Wednesday, November 29th.

Mesa Laboratories has increased its dividend payment by an average of 3.9% per year over the last three years. Mesa Laboratories has a dividend payout ratio of 24.7% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Mesa Laboratories to earn $3.40 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 18.8%.

Shares of Mesa Laboratories (MLAB) traded up 0.67% on Tuesday, hitting $152.50. The stock had a trading volume of 10,166 shares. The firm has a 50 day moving average of $138.50 and a 200-day moving average of $140.07. Mesa Laboratories has a 1-year low of $109.14 and a 1-year high of $169.81. The firm has a market capitalization of $573.10 million, a price-to-earnings ratio of 54.82 and a beta of 0.48.

Mesa Laboratories (NASDAQ:MLAB) last issued its earnings results on Monday, July 31st. The medical instruments supplier reported $0.39 EPS for the quarter, missing the consensus estimate of $0.56 by ($0.17). Mesa Laboratories had a return on equity of 16.58% and a net margin of 11.31%. The firm had revenue of $22.67 million during the quarter, compared to analysts’ expectations of $22.90 million. Equities analysts predict that Mesa Laboratories will post $2.74 earnings per share for the current year.

A number of brokerages have issued reports on MLAB. Zacks Investment Research raised shares of Mesa Laboratories from a “hold” rating to a “buy” rating and set a $159.00 price target on the stock in a report on Tuesday, June 13th. TheStreet downgraded shares of Mesa Laboratories from a “b” rating to a “c+” rating in a research note on Monday, July 31st. Finally, BidaskClub downgraded shares of Mesa Laboratories from a “hold” rating to a “sell” rating in a research note on Monday, July 31st.

In other Mesa Laboratories news, Director H Stuart Campbell sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $143.37, for a total transaction of $286,740.00. Following the completion of the transaction, the director now owns 49,976 shares of the company’s stock, valued at approximately $7,165,059.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In the last 90 days, insiders have sold 8,610 shares of company stock worth $1,176,809. 15.70% of the stock is owned by company insiders.

COPYRIGHT VIOLATION NOTICE: “Mesa Laboratories, Inc. (MLAB) to Issue Quarterly Dividend of $0.16” was published by American Banking News and is owned by of American Banking News. If you are viewing this piece on another publication, it was illegally copied and republished in violation of U.S. and international copyright laws. The original version of this piece can be viewed at

Mesa Laboratories Company Profile

Mesa Laboratories, Inc is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products.

Dividend History for Mesa Laboratories (NASDAQ:MLAB)

Receive News & Ratings for Mesa Laboratories Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories Inc. and related companies with's FREE daily email newsletter.